Vivo Capital, LLC - 维梧资本

Vivo Capital, LLC is a private equity and venture capital firm specializing in incubation, growth capital, early stage, mid venture, late stage, seed, startup, mezzanine, buyout, public equity, privatizations, spin-off, small to mid-cap public companies, PIPE investments in private and public companies, follow-on financings, private placements, initial public offerings, secondaries, ATM purchases and block trades. The firm seeks to invest in all financing stages from Series A to public companies. It primarily invests in healthcare including healthcare services, biotechnology, specialty pharmaceuticals, bio-pharmaceutical and bio-medical, drugs, vaccines, medical equipment, medical and health services, medicine, vaccines, medical appliances and life science companies. The firm also seeks to invest in companies with later-stage therapeutic products in clinical development. It typically makes investments in Europe, Sino-US region, China with a focus on Chengdu, North America, United States and Asia Pacific based companies with a focus on later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China also invest in companies outside the United States and Asia/Pacific. The firm seeks to invest between $2 million to $40 million. The firm prefers minority equity investments to control and majority transactions. Vivo Capital, LLC was founded in 1996 and is based in Palo Alto, California with additional offices in Beijing, China; Shanghai, China; Hong Kong, Hong Kong and Taipei, Taiwan.